title: How do intellectual property law and international trade agreements affect access to antiretroviral therapy?
authors.affiliation: Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States.
authors.forename: Michael
authors.initials: M
authors.lastname: Westerhaus
authors.forename: Arachu
authors.initials: A
authors.lastname: Castro
mesh_terms: D044966:Anti-Retroviral Agents / Q000600:supply & distribution*; D003132:Commerce / Q000331:legislation & jurisprudence*; D004345:Drug Industry; D014943:Global Health; D006297:Health Services Accessibility; D006801:Humans; D018973:Intellectual Property; D007391:International Cooperation; D010330:Patents as Topic; D014481:United States
chemical_list: D044966:Anti-Retroviral Agents